Cargando…

Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study

BACKGROUND: Diabetes is the sixth leading cause of death and results in significant morbidity. The purpose of this study is to determine what demographic, health status, treatment, access/quality of care, and behavioral factors are associated with poor glycemic control in a Type 2 diabetic, low-inco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benoit, Stephen R, Fleming, Regina, Philis-Tsimikas, Athena, Ji, Ming
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090595/ https://www.ncbi.nlm.nih.gov/pubmed/15833140 http://dx.doi.org/10.1186/1471-2458-5-36

Ejemplares similares

Predictors of Dropouts From a San Diego Diabetes Program: A Case Control Study
por: Benoit, Stephen R., et al.
Publicado: (2004)

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes
por: Philis-Tsimikas, Athena
Publicado: (2008)

Peer-Led Diabetes Education Programs in High-Risk Mexican Americans Improve Glycemic Control Compared With Standard Approaches: A Project Dulce promotora randomized trial
por: Philis-Tsimikas, Athena, et al.
Publicado: (2011)

Digital health tools to promote diabetes education and management of cardiovascular risk factors among under-resourced populations
por: Paul, Tenes, et al.
Publicado: (2021)

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges
por: King, Allen B., et al.
Publicado: (2017)

Periodic Intensive Insulin Therapy Remains Experimental
por: Chang, Amy, et al.
Publicado: (2019)

Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico
por: Anzaldo-Campos, María Cecilia, et al.
Publicado: (2016)

Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)
por: Philis-Tsimikas, Athena, et al.
Publicado: (2013)

Improving Treatment of Depression Among Latinos With Diabetes Using Project Dulce and IMPACT
por: Gilmer, Todd P., et al.
Publicado: (2008)

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
por: Rose, Ludger, et al.
Publicado: (2019)

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation
por: Weatherall, James, et al.
Publicado: (2018)

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
por: Zinman, Bernard, et al.
Publicado: (2012)

Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial
por: Chaykin, Louis, et al.
Publicado: (2019)

100 years on: the impact of the discovery of insulin on clinical outcomes
por: Buse, John B, et al.
Publicado: (2021)

The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2020)

Predictors of poor glycemic control and level of glycemic control among diabetic patients in west Ethiopia
por: Dedefo, Mohammed Gebre, et al.
Publicado: (2020)

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2019)

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial
por: Mathieu, Chantal, et al.
Publicado: (2018)

Longitudinal Analysis of Depressive Symptoms and Glycemic Control in Type 2 Diabetes
por: Aikens, James E., et al.
Publicado: (2009)

Predictors of self-care behaviors and glycemic control among patients with type 2 diabetes mellitus
por: Babazadeh, Towhid, et al.
Publicado: (2023)

Longitudinal Associations Between Illness Perceptions and Glycemic Control in Type 2 Diabetes
por: Alyami, Mohsen, et al.
Publicado: (2021)

Patterns and Predictors of Long-Term Glycemic Control in Patients with Type 2 Diabetes
por: Janghorbani, Mohsen, et al.
Publicado: (2012)

Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial
por: Pieber, Thomas R., et al.
Publicado: (2021)

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
por: Philis-Tsimikas, Athena, et al.
Publicado: (2020)

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
por: Philis-Tsimikas, A, et al.
Publicado: (2013)

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (BEGIN: ADD TO GLP‐1 Study)
por: Aroda, V. R., et al.
Publicado: (2016)

Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials
por: Janez, Andrej, et al.
Publicado: (2020)

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2022)

Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting
por: Fortmann, Addie L., et al.
Publicado: (2020)

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Predictors of poor glycemic control in adult with type 2 diabetes in South-Eastern Nigeria
por: Anioke, Innocent Chidi, et al.
Publicado: (2019)

Trends and Predictors of Glycemic Control Among Adults With Type 2 Diabetes Covered by Alabama Medicaid, 2011–2019
por: Presley, Caroline A., et al.
Publicado: (2023)

Predictors of glycemic control in children with Type 1 diabetes mellitus in Assiut-Egypt
por: Mohammad, Hanaa A., et al.
Publicado: (2012)

Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials
por: DeVries, J. Hans, et al.
Publicado: (2018)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
por: Rodbard, H W, et al.
Publicado: (2013)

Diabetes knowledge and glycemic control among patients with type 2 diabetes in Bangladesh
por: Islam, Sheikh Mohammed Shariful, et al.
Publicado: (2015)

Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study
por: Blumenthal, Karen J, et al.
Publicado: (2010)

Effect of Health Information Technologies on Glycemic Control Among Patients with Type 2 Diabetes
por: Yoshida, Yilin, et al.
Publicado: (2018)

Depression, glycemic control and type 2 diabetes
por: Papelbaum, Marcelo, et al.
Publicado: (2011)

Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3tnmrlv4f98um3j6ahqnhnte8